Open Tender Watch
Menu v
ACCESS EN PT
← Companies Company PT

BAXTER - MÉDICO FARMACÊUTICA, LDA

NIF 503347345
↓ CSV ↓ JSON
Risk Flags
A1 · Repeat Direct Award €6,115,752 104 contracts
Same supplier receives ≥2 direct awards in 36 months with cumulative value above the CCP Art. 113 §2 statutory cap
HIGH €6,115,752 104 contracts
A2 · Late Publication €11,002,969,091 5,839 contracts
Contract published to BASE more than 10 days after the signing date
LOW €11,002,969,091 5,839 contracts
A5 · Threshold Splitting €10,496,036 228 contracts
Contract value falls within 5% below a procedural threshold (€5K / €20K / €75K / €150K / €5.35M). Score: 35 · Severity: Medium.
HIGH €10,496,036 228 contracts
A6 · Low Competition €1,786,645 24 contracts
Only one bidder participated in a competitive procedure
MEDIUM €1,786,645 24 contracts
A9 · Price Overrun €14,800 6 contracts
Effective price exceeds base price by >50% (score 30) or >100% (score 55); or effective price is <50% of base (score 10, possible predatory bid or data error). Severity: Medium/High/Low.
HIGH €14,800 6 contracts
A9 · Abnormal Price Reduction €12,440,067,982 2,291 contracts
Effective price exceeds base price by >50% (score 30) or >100% (score 55); or effective price is <50% of base (score 10, possible predatory bid or data error). Severity: Medium/High/Low.
LOW €12,440,067,982 2,291 contracts
B5 · Benford's Law Deviation €1,248,688,696 4 contracts
Entity's contract values deviate from the Benford leading-digit distribution (chi-square goodness-of-fit, min 20 contracts). Score: 35 (p<0.05) or 55 (p<0.01).
HIGH €1,247,737,134 3 contracts
MEDIUM €951,562 1 contracts
C3 · Missing Mandatory Fields €7,191,203 129 contracts
CPV code, procedure type, or base price absent for the procedure type, or base price exceeds ±€1 trillion (implausible data entry). Score: 20 · Severity: Low.
LOW €7,191,203 129 contracts

Procurement Network

Aggregated links between this entity and connected counterparties

Public view excludes person-level links and tax identifiers.

Loading network…
Legend Focus entity Public body Company Anonymized individual

Contracts by Contracting Authority

134
€2,678,026,460
784
€477,671,323
181
€470,989,306
79
€465,021,552
183
€419,001,363
364
€404,488,995
292
€404,163,256
83
€395,813,178
68
€389,351,375
87
€366,687,942
525
€359,617,217
345
€345,278,647
39
€321,458,754
47
€317,892,976
169
€317,782,790
95
€310,649,080
57
€302,833,077
96
€297,681,768
1,432
€293,689,478
44
€293,081,745
Page 1 of 4 · 73 authorities
Next →

All Contracts Won

Signal: All A1 · Repeat Direct Award A2 · Late Publication A5 · Threshold Splitting A6 · Low Competition A9 · Price Overrun A9 · Abnormal Price Reduction B5 · Benford's Law Deviation C3 · Missing Mandatory Fields

Page 1 of 1 · 6 contracts

Medicamentos
PT · bca058442666b3a6b9bf · Ajuste Direto Regime G...
A9 · Price Overrun
€7,710 2025-06-26
Medicamentos
PT · f753af21d89e832b7d16 · Ajuste Direto Regime G...
A9 · Price Overrun
€253 2025-06-26
Medicamentos
PT · c34e19144404c153f903 · Ajuste Direto Regime G...
A2 · Late Publication A9 · Price Overrun
€298 2025-06-12
Medicamentos
PT · 4274cd7bfe2b0f70cdeb · Ajuste Direto Regime G...
A2 · Late Publication A9 · Price Overrun
€5,733 2025-06-03
Medicamentos
PT · b2b18e09a792273c1950 · Ajuste Direto Regime G...
A2 · Late Publication A9 · Price Overrun
€417 2025-06-03
Medicamentos
PT · b8922c1bfd977c2913eb · Ajuste Direto Regime G...
A2 · Late Publication A9 · Price Overrun
€386 2025-06-03
Overview
Total Value Won
€12,638,286,180
Contracts Won
8,248
Score 273240 · CRITICAL RISK
NIF
503347345
Country
PT
Directors & Officers

Personal data is pseudonymised for public access. Authenticate with a journalist token to view full names and NIFs.

  • A.I. [P-79fd]
    Gerente
    since 2025-10-23
  • J.C. [P-c446]
    Gerente
    since 2009-06-15
  • B.S. [P-4f8d]
    Sócio
    since 2012-03-30
  • B.S. [P-4f8d]
    Sócio
    since 2023-12-05
  • C.C. [P-4662]
    Gerente
    2017-02-01 → 2020-10-24
  • I.S. [P-4636]
    Gerente
    2015-06-30 → 2017-02-01
  • J.M. [P-1d49]
    Gerente
    until 2015-06-30
  • J.C. [P-c446]
    Gerente
    until 2010-09-09
  • L.A. [P-8922]
    Gerente
    2012-03-30 → 2020-10-24
  • M.V. [P-ade7]
    Gerente
    2023-11-14 → 2025-10-23
  • P.M. [P-613e]
    Gerente
    2012-03-30 → 2015-06-30
  • S.K. [P-7ab7]
    Gerente
    2020-10-24 → 2023-11-14
Ownership & Registries

Beneficial ownership data (shareholders, directors, ultimate beneficial owners) is not yet imported. Links below open external public registries.

Registo Comercial (MJ) ↗ RCBE — Beneficial Ownership Register ↗

Full RCBE access requires judicial authentication (CJEU 2022 ruling limits public exposure).

Search in TED (EU procurement) ↗
Phase 7 — ownership layer planned